Publications
- Adverse effects of combination immunotherapy in renal cancer, lung cancer, and melanoma +12022 | Faculty of Medicine in Hradec Králové
- Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer2020 | Faculty of Medicine in Hradec Králové
- How to manage side effects of immunotherapy How to manage side effects of immunotherapy2020 | Faculty of Medicine in Hradec Králové
- Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years2020 | Faculty of Medicine in Hradec Králové
- Pembrolizumab in pretreated patient2018 | Faculty of Medicine in Hradec Králové
- Plasma filtration for the controlled removal of liposomal therapeutics - From the apheretic site of view2017 | Faculty of Medicine in Hradec Králové
- The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review2017 | Faculty of Medicine in Hradec Králové
- Immune-related adverse events2017 | Faculty of Medicine in Hradec Králové
- Extracorporeal apheresis system - A nanoparticle drugs' elimination method to enhance the benefit of cytostatic therapy in cancer patients2016 | Faculty of Medicine in Hradec Králové
- Adverse Effects of Modern Treatment of Malignant Melanoma and their Treatment/Management2014 | Faculty of Medicine in Hradec Králové
Loading network view...